Biotechnology News

June 28, 2012

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) announced today it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for marketing approval of cobicistat, a pharmacoenhancing or “...

June 28, 2012

SAN BRUNO, Calif.--(BUSINESS WIRE)--Numerate, Inc., which is transforming the drug discovery process through the use of cloud computing and proprietary algorithms, is one of several companies to use the new Google Compute Engine.

June 28, 2012

EATONTOWN, N.J.--(BUSINESS WIRE)--Flexible Stenting Solutions, Inc. (“FSS”), a leading developer of next generation peripheral arterial, venous, neurovascular and biliary stents, announced today that it has extended its CE Mark authorized family...

June 28, 2012

PHILADELPHIA--(BUSINESS WIRE)--Today’s Supreme Court decision came during the DIA 2012 Annual Meeting CDER Town Hall—generating mixed reaction from the 600 people in attendance.

June 28, 2012

BLOOMINGTON, Ind.--(BUSINESS WIRE)--Cook Medical calls for the U.S. Senate to repeal the 2.3 percent medical device excise tax

June 28, 2012

BETHESDA, Md.--(BUSINESS WIRE)--Sucampo announced that Silvia Taylor has joined as Senior Vice President, Investor Relations, Public Relations and Corporate Communications.

June 28, 2012

WASHINGTON--(BUSINESS WIRE)--BIO President and CEO has released a statement on the ruling issued today by the U.S. Supreme Court regarding the Affordable Care Act.

June 28, 2012

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Fluxion Biosciences, Inc. announced today that it has initiated a collaboration with the Stanford University School of Medicine focused on developing tests to help deliver more effective therapies to...

June 28, 2012

STOCKHOLM--(BUSINESS WIRE)--Regulatory News: Precise Biometrics (STO:PREC), an innovation leader in providing authentication solutions, and developer of Tactivo™, a smart casing that provides both smart card and fingerprint authentication to...

June 28, 2012

BERKELEY, Calif.--(BUSINESS WIRE)--Emergence Venture Partners, a venture firm that is focused on the application of novel biomedical polymer technology in the development of medical devices and prosthetic implants, announced today that Bob Ward,...

June 28, 2012

MADISON, Wis.--(BUSINESS WIRE)--The 23rd International Symposium on Human Identification (ISHI) is October 15-18, 2012 in Nashville, Tennessee, USA

June 28, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Millennium: The Takeda Oncology Company with its parent company Takeda Pharmaceutical Company Limited (TSE:4502) today announced the initiation of an international phase 3 clinical trial evaluating MLN9708 in...

June 28, 2012

LOS ANGELES--(BUSINESS WIRE)--Response Genetics, Inc. (NASDAQ:RGDX), a company focused on the development and sale of molecular diagnostic tests for cancer, today announced a new anaplastic lymphoma kinase (ALK) testing program aimed to provide...

June 28, 2012

SAN FRANCISCO--(BUSINESS WIRE)--Gemmus closed on a Series A financing led by the Life Science Angels. Gemmus is developing a new host-based treatment for flu. Gemmus is part of QB3, a San Francisco incubator at UCSF Mission Bay.

June 28, 2012

SAN ANTONIO--(BUSINESS WIRE)--Data on GenSpera's drug, G-202, published in Journal of Translational Medicine. Validates target and delivery strategy.

June 28, 2012

BURLINGTON, Mass.--(BUSINESS WIRE)--Dyax Corp. (NASDAQ:DYAX) will host a webcast and conference call, including an open question and answer session, Thursday, July 19, 2012. During the call, management will discuss the Company’s financial results...

June 28, 2012

ALEXANDRIA, Va.--(BUSINESS WIRE)--MPR Product Development hires Bruce Gray as Senior Project Manager to lead the development of cardiovascular, peripheral vascular, and neurological products.

June 28, 2012

EXTON, Pa.--(BUSINESS WIRE)--The availability of the anti-JC virus antibody assay appears to be contributing to the significant increase in overall satisfaction with Biogen Idec / Elan’s Tysabri over the past year

June 28, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Verastem will host its annual Research and Development Day on July 12, 2012. The program includes a seminar on cancer stem cells by Robert Weinberg, Ph.D.

June 28, 2012

TORONTO--(BUSINESS WIRE)--While more mature orthopedic markets, such as hips and knees, are fairly saturated, extremities are relatively untapped, and manufacturers have been investing heavily in this market, seeking growth.

June 28, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) will be presenting at the Seventh Annual JMP Securities Healthcare Conference on July 12, 2012, at 9:00 a.m. ET in New York City. A live webcast of Infinity's...

June 28, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Final Phase 2 Data from Combination Study of VX-809 and KALYDECO™ Showed Statistically Significant Improvements in Lung Function in People with CF Who Have 2 Copies of the F508del Mutation

June 28, 2012

JERUSALEM--(BUSINESS WIRE)--BioLineRx announced that its Chief Financial and Operating Officer, Philip Serlin, will be presenting at the 2012 Annual JMP Securities Healthcare Conference at the Peninsula Hotel in New York.

June 28, 2012

SAN CARLOS, Calif.--(BUSINESS WIRE)--Research grant award to be funded by NuGEN Technologies. Winner will receive up to $10,000 in NuGEN reagents for NGS study. Study proposals being accepted until August 15, 2012.

June 28, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--BioCryst Pharmaceuticals to present at the 7th Annual JMP Securities Healthcare Conference in New York on Thursday, July 12, 2012 at 9 a.m. ET

June 28, 2012

ATLANTA--(BUSINESS WIRE)--Dr. Bobby Khan, Executive Director of Carmel Biosciences, was presented with the award for Outstanding Business Collaboration between the U.S. and India at a ceremony in Atlanta on June 21, 2012. The award was conferred...

June 27, 2012

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq:GILD) announced today it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for marketing approval of elvitegravir, an integrase inhibitor...

June 27, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--Synta Announces Results from Interim Analysis of the Randomized Phase 2b/3 GALAXY Trial Evaluating Ganetespib plus Docetaxel in Second-Line NSCLC.

June 27, 2012

CRANBURY, N.J.--(BUSINESS WIRE)--NJ Lt. Governor visits biotech VaxInnate on tour of state's life sciences company.

June 27, 2012

MINNEAPOLIS--(BUSINESS WIRE)--A patent has issued supporting a long-term research and development collaboration to develop and commercialize a safe and effective means to prevent or slow the progression of Alzheimer’s disease.

June 27, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today reported preclinical data for IPI-145, the company’s oral inhibitor of phosphoinositide-3-kinase (PI3K)-delta and PI3K-gamma. The data demonstrate potent PI3K-...

June 27, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--The Board of Directors of PerkinElmer, Inc. (NYSE: PKI) declared a regular quarterly dividend of $0.07 per share of common stock on June 15, 2012. This dividend is payable on August 10, 2012, to all shareholders...

June 27, 2012

DENVER--(BUSINESS WIRE)--Accelr8 Technology Corporation (NYSE MKT: AXK) today announced the appointment of Lawrence Mehren as President and Chief Executive Officer and a member of the Board of Directors. Most recently, Mr. Mehren was Head of...

June 27, 2012

DENVER--(BUSINESS WIRE)--Accelr8 Technology Corporation (NYSE MKT: AXK) announced today that it has received shareholder approval, met all closing conditions, and has consummated a transaction that will result in an investment of up to $35...

June 27, 2012

SUNNYVALE, Calif.--(BUSINESS WIRE)--Aptus Endosystems, Inc., a medical device company developing advanced technology for endovascular aneurysm repair (EVAR), announced closing on $25 million of equity financing.

June 27, 2012

PHILADELPHIA--(BUSINESS WIRE)--The DIA 2012 Annual Meeting convened three of the most influential regulatory agencies--FDA, EMA, and Health Canada--to discuss regulatory collaboration in the 21st Century.

June 27, 2012

NEW YORK--(BUSINESS WIRE)--Tonix Pharmaceuticals Holding Corp. (OTCBB: TNXP) (“TONIX” or the “Company”), which specializes in non-addictive treatments for chronic pain syndrome disorders, announces that Chief Executive Officer, Seth Lederman, M.D...

June 27, 2012

LOS ANGELES--(BUSINESS WIRE)--Trifecta Multimedical announces the launch of InvestigatorSpace.com. Two years in the making, InvestigatorSpace.com provides state-of-the-art capabilities for investigator training and site operations....

June 27, 2012

DAVIS, Calif.--(BUSINESS WIRE)--Gold Standard Diagnostics (GSD) today announced FDA clearance of its next-generation Lyme disease Line Immunoassay which offers excellent specificity and sensitivity at any disease stage.

June 27, 2012

IRVINE, Calif.--(BUSINESS WIRE)--Concluding a series of conference presentations in recent months, California Stem Cell (CSC) Medical Director and Principal Investigator Robert O. Dillman, M.D. will be delivering an oral presentation at today’s...

June 27, 2012

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE: BAX) today issued its 2011 Sustainability Report, marking the 13th consecutive year the company has released a report about its social, environmental and economic performance. The...

June 27, 2012

DAVIS, Calif. & HYDERABAD, India--(BUSINESS WIRE)--Arcadia Biosciences, Inc., an agricultural technology company focused on developing technologies and products that benefit the environment and human health, and Bioseed Research India Pvt....

June 27, 2012

EMERYVILLE, Calif.--(BUSINESS WIRE)--Parkinson's Disease research receives $1.2 Million funding boost from the Michael J. Fox Foundation to develop critical "kinetic biomarkers" that identify and measure brain disease processes

June 27, 2012

HAMILTON, Bermuda & LONDON & NEW YORK--(BUSINESS WIRE)--Data presented today by Dr. Stewart Goldman showed positive results in Phase I/II study of Xerecept in Pediatric Patients with Peritumoral Cerebral Edema.

June 27, 2012

BURLINGTON, Mass.--(BUSINESS WIRE)--Infraredx, Inc., a medical device company committed to advancing the diagnosis and management of coronary artery and other vascular diseases, today announced that the company has signed an exclusive five-year...

June 27, 2012

LONDON--(BUSINESS WIRE)--New “2012 Strategic Analysis of the Global Coagulation Testing Market: Forecasts and Supplier Shares by Country” by Venture Planning Group has been recently published by Market Publishers Ltd.

June 27, 2012

NEUHAUSEN AM RHEINFALL, Switzerland--(BUSINESS WIRE)--Join a live presentation of LifeWatch V today: Live Video Webcast in the IR section on www.lifewatch.com; Product website:...

June 27, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, announced today that it has expanded and developed its management team with new appointments and promotions. The company has...